gemcitabine (low-dose)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for gemcitabine (low-dose), covering 2024-04-03 to 2024-04-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study of GB201 in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer [Phase 2, Phase 3]